116 related articles for article (PubMed ID: 6159140)
21. [On the multivariate analysis of biochemical liver function tests in relation to histopathological diagnosis--with special reference to mass screening of hepatocellular carcinoma].
Hirata K; Fukuda M; Mima S
Rinsho Byori; 1985 Mar; 33(3):239-48. PubMed ID: 2989588
[No Abstract] [Full Text] [Related]
22. [Mass survey of hepatocellular cancer].
Fukuda M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):505-9. PubMed ID: 3019853
[No Abstract] [Full Text] [Related]
23. Surveillance and diagnosis for hepatocellular carcinoma.
Aljabiri MR; Lodato F; Burroughs AK
Liver Transpl; 2007 Nov; 13(11 Suppl 2):S2-12. PubMed ID: 17969087
[No Abstract] [Full Text] [Related]
24. Pregnancy associated with primary hepatocellular carcinoma.
Wang LR; Jeng CJ; Chu JS
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):811-3. PubMed ID: 7682318
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma. New directions in etiology.
Maltz C; Lightdale CJ; Winawer SJ
Am J Gastroenterol; 1980 Oct; 74(4):361-5. PubMed ID: 6161536
[No Abstract] [Full Text] [Related]
26. [Clinical analysis of low AFP level cases and their prognosis (author's transl)].
Xu KL; Li ML; Guan SF; Yu EX; Song MZ; Shen YX
Zhonghua Zhong Liu Za Zhi; 1980 Mar; 2(1):45-9. PubMed ID: 6160027
[No Abstract] [Full Text] [Related]
27. Alpha foetoprotein in liver disease.
Sehgal S; Aikat BK
Indian J Med Res; 1977 Mar; 65(3):416-21. PubMed ID: 72729
[No Abstract] [Full Text] [Related]
28. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Hu KQ; Kyulo NL; Lim N; Elhazin B; Hillebrand DJ; Bock T
Am J Gastroenterol; 2004 May; 99(5):860-5. PubMed ID: 15128351
[TBL] [Abstract][Full Text] [Related]
29. [A new model for survival assessment based on the Chinese liver transplantation patients with hepatocellular carcinoma].
Zhang M; Li B; Yin F; Yan LN; Zeng Y; Wen TF; Zhao JC; Luo YL
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(15):1023-6. PubMed ID: 18005580
[TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic syndromes in primary liver-cell carcinoma: experience in Ibadan, Nigeria.
Ayoola EA
Afr J Med Med Sci; 1980; 9(3-4):163-7. PubMed ID: 6178279
[TBL] [Abstract][Full Text] [Related]
31. Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Yao FY
Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766
[No Abstract] [Full Text] [Related]
32. Screening and treatment for hepatocellular carcinoma.
Sherman M; Takayama Y
Gastroenterol Clin North Am; 2004 Sep; 33(3):671-91, xi. PubMed ID: 15324950
[TBL] [Abstract][Full Text] [Related]
33. [Biological markers of hepatocellular carcinoma].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
[TBL] [Abstract][Full Text] [Related]
34. Alpha1 foetoprotein in liver cell carcinoma--Detection in serum using the A.F.P. slide test.
Hanchard B; Brooks SE; Terry S
West Indian Med J; 1979 Jun; 28(2):77-9. PubMed ID: 89760
[No Abstract] [Full Text] [Related]
35. Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation.
Du XL; Ma QJ; Wu T; Bao GQ; Lu JG; Chu YK
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):172-5. PubMed ID: 17374577
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
37. Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Huo TI; Lee SD
Liver Int; 2006 Dec; 26(10):1300-1. PubMed ID: 17105599
[No Abstract] [Full Text] [Related]
38. Spatial analysis of hepatocellular carcinoma and socioeconomic status in China from a population-based cancer registry.
Peng W; Chen Y; Jiang Q; Zheng Y
Cancer Epidemiol; 2010 Feb; 34(1):29-33. PubMed ID: 20075018
[TBL] [Abstract][Full Text] [Related]
39. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Li X; Wu K; Fan D
Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
[No Abstract] [Full Text] [Related]
40. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
